These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9914599)

  • 1. A high-sensitivity alternative to "routine" genetic amniocentesis: multiple urinary analytes, nuchal thickness, and age.
    Bahado-Singh R; Oz U; Kovanci E; Cermik D; Copel J; Mahoney MJ; Cole L
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):169-73. PubMed ID: 9914599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuchal thickness, urine beta-core fragment level, and maternal age for down syndrome screening.
    Bahado-Singh RO; Oz AU; Flores D; Cermik D; Acuna E; Mahoney MJ; Cole L
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):491-5. PubMed ID: 9988824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
    Bahado-Singh R; Shahabi S; Karaca M; Mahoney MJ; Cole L; Oz UA
    Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new screening protocol combining urine beta-core fragment and ultrasonography for Down syndrome detection.
    Bahado-Singh RO; Oz UA; Deren O; Acuna E; Cermik D; Mahoney MJ; Cole L
    Am J Obstet Gynecol; 1998 Apr; 178(4):779-82. PubMed ID: 9579443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of nuchal thickness to humerus length for Down syndrome detection.
    Bahado-Singh RO; Oz U; Hsu CD; Deren O; Copel JA; Mahoney MJ
    Am J Obstet Gynecol; 2001 May; 184(6):1284-8. PubMed ID: 11349203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk.
    Bahado-Singh RO; Oz UA; Kovanci E; Deren O; Feather M; Hsu CD; Copel JA; Mahoney MJ
    J Matern Fetal Med; 1999; 8(2):37-43. PubMed ID: 10090488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results.
    Bahado-Singh RO; Goldstein I; Uerpairojkit B; Copel JA; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1106-10. PubMed ID: 7485301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
    Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary screening tests for fetal Down syndrome: I. Fresh beta-core fragment.
    Cole LA; Rinne KM; Mahajan SM; Oz UA; Shahabi S; Mahoney MJ; Bahado-Singh RO
    Prenat Diagn; 1999 Apr; 19(4):340-50. PubMed ID: 10327140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New triple screen test for Down syndrome: combined urine analytes and serum AFP.
    Bahado-Singh RO; Oz U; Kovanci E; Cermik D; Flores D; Copel J; Mahoney M; Cole L
    J Matern Fetal Med; 1998; 7(3):111-4. PubMed ID: 9642606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome.
    Locatelli A; Piccoli MG; Vergani P; Mariani E; Ghidini A; Mariani S; Pezzullo JC
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):192-7. PubMed ID: 10649178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome.
    Kellner LH; Canick JA; Palomaki GE; Neveux LM; Saller DN; Walker RP; Osathanondh R; Bombard AT
    Prenat Diagn; 1997 Dec; 17(12):1135-41. PubMed ID: 9467810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
    Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative for women initially declining genetic amniocentesis: individual Down syndrome odds on the basis of maternal age and multiple ultrasonographic markers.
    Bahado-Singh R; Deren O; Oz U; Tan A; Hunter D; Copel J; Mahoney MJ
    Am J Obstet Gynecol; 1998 Aug; 179(2):514-9. PubMed ID: 9731862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined second-trimester biochemical and ultrasound screening for Down syndrome.
    Benn PA; Kaminsky LM; Ying J; Borgida AF; Egan JF
    Obstet Gynecol; 2002 Dec; 100(6):1168-76. PubMed ID: 12468159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
    Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
    Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.